- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Novartis AG (NOVN)
| Open: | 50.150 | Day's Range: | 50.000 - 50.450 | Volume: | 2,807,414 | Bid: | 50.200 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 49.920 | 52wk Range: | 38.910 - 55.050 | 1-Yr Rtn: | -3.01% | Ask: | 50.250 |
Key Statistics for NOVN
| Current P/E Ratio (ttm) | 14.6034 |
|---|---|
| Estimated P/E (12/2012) | 9.5729 |
| Earnings Per Share (USD) (ttm) | 3.5700 |
| Est. EPS (USD) (12/2012) | 5.4460 |
| Est. PEG Ratio | 2.1283 |
| Market Cap (M CHF) | 135,850.89 |
| Shares Outstanding (M) | 2,706.19 |
| Enterprise Value (M USD) (ttm) | 160,291.15 |
| Enterprise Value/EBITDA (ttm) | 9.34 |
| Price/Book (mrq) | 1.9981 |
| Price/Sale (ttm) | 2.1513 |
| Dividend Indicated Gross Yield | 4.4821 |
| Next Earnings Announcement | 07/19/2012 |
More NOVN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for NOVN
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for NOVN
Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis, vaccines and diagnostics, vision, and animal health products.
| Daniel L VasellaChairman | Ulrich LehnerCo-Vice Chairman |
| Joseph Jimenez Jr "Joe"Chief Executive Officer | Jonathan R Symonds "Jon"Chief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page